Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left guessing how to achieve similar results.

Alphabet-backed start-up Isomorphic Labs has added another name to the roster of pharma companies tapping into its AI-based drug discovery engine. Johnson & Johnson's Janssen Biotech unit is the ...

Read more: A сentury of сhemical warfare: why the global ban matters Swiss becomes first woman to head chemical weapons body Read more: Swiss becomes first woman to head chemical weapons body Bad ...

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.

Add Yahoo as a preferred source to see more of our stories on Google. Demis Hassabis speaks during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 20, 2026.

Ohio State football players are awarded Buckeye leaf stickers to place on helmets for certain achievements Todd Kirkland/Getty The Ohio State University football team has helmets covered in buckeye ...

As the world prepares to welcome 2026, WhatsApp has rolled out a series of limited-time festive updates designed to make New Year celebrations more fun, vibrant and connected. The Meta-owned messaging ...

There’s a fun way to personalize your iPhone 17 Pro: tiny stickers around the camera. Social media is blowing up with pictures from people showing off how cool their handset looks with the new ...